BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33199827)

  • 1. HDAC6 promotes growth, migration/invasion, and self-renewal of rhabdomyosarcoma.
    Pham TQ; Robinson K; Xu L; Pavlova MN; Skapek SX; Chen EY
    Oncogene; 2021 Jan; 40(3):578-591. PubMed ID: 33199827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silence of HDAC6 suppressed esophageal squamous cell carcinoma proliferation and migration by disrupting chaperone function of HSP90.
    Tao H; Chen YY; Sun ZW; Chen HL; Chen M
    J Cell Biochem; 2018 Aug; 119(8):6623-6632. PubMed ID: 29665050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propolin G-Suppressed Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells via Glycogen Synthase Kinase 3β-Mediated Snail and HDAC6-Regulated Vimentin Degradation.
    Pai JT; Chen XH; Leu YL; Weng MS
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting PAK4 Inhibits Ras-Mediated Signaling and Multiple Oncogenic Pathways in High-Risk Rhabdomyosarcoma.
    Dasgupta A; Sierra L; Tsang SV; Kurenbekova L; Patel T; Rajapakse K; Shuck RL; Rainusso N; Landesman Y; Unger T; Coarfa C; Yustein JT
    Cancer Res; 2021 Jan; 81(1):199-212. PubMed ID: 33168646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetically upregulated GEFT-derived invasion and metastasis of rhabdomyosarcoma via epithelial mesenchymal transition promoted by the Rac1/Cdc42-PAK signalling pathway.
    Liu C; Zhang L; Cui W; Du J; Li Z; Pang Y; Liu Q; Shang H; Meng L; Li W; Song L; Wang P; Xie Y; Wang Y; Liu Y; Hu J; Zhang W; Li F
    EBioMedicine; 2019 Dec; 50():122-134. PubMed ID: 31761617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Proprotein Convertase Furin Contributes to Rhabdomyosarcoma Malignancy by Promoting Vascularization, Migration and Invasion.
    Jaaks P; D'Alessandro V; Grob N; Büel S; Hajdin K; Schäfer BW; Bernasconi M
    PLoS One; 2016; 11(8):e0161396. PubMed ID: 27548722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness.
    Leyk J; Daly C; Janssen-Bienhold U; Kennedy BN; Richter-Landsberg C
    Cell Death Dis; 2017 Aug; 8(8):e3028. PubMed ID: 29048427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cell migration and induction of apoptosis by a novel class II histone deacetylase inhibitor, MCC2344.
    Dawood M; Fleischer E; Klinger A; Bringmann G; Shan L; Efferth T
    Pharmacol Res; 2020 Oct; 160():105076. PubMed ID: 32659428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of MET signaling by HDAC6 offers a rationale for a novel ricolinostat and crizotinib combinatorial therapeutic strategy in diffuse large B-cell lymphoma.
    Liu Z; Cai Y; Yang Y; Li A; Bi R; Wang L; Shen X; Wang W; Jia Y; Yu B; Cao B; Cui W; Wei P; Zhou X
    J Pathol; 2018 Oct; 246(2):141-153. PubMed ID: 29876933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC6 regulates neuroblastoma cell migration and may play a role in the invasion process.
    Zhang L; Liu N; Xie S; He X; Zhou J; Liu M; Li D
    Cancer Biol Ther; 2014; 15(11):1561-70. PubMed ID: 25482939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase 6 promotes growth of glioblastoma through the MKK7/JNK/c-Jun signaling pathway.
    Huang Z; Xia Y; Hu K; Zeng S; Wu L; Liu S; Zhi C; Lai M; Chen D; Xie L; Yuan Z
    J Neurochem; 2020 Jan; 152(2):221-234. PubMed ID: 31390677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic prostate cancer-associated P62 inhibits autophagy flux and promotes epithelial to mesenchymal transition by sustaining the level of HDAC6.
    Jiang X; Huang Y; Liang X; Jiang F; He Y; Li T; Xu G; Zhao H; Yang W; Jiang G; Su Z; Jiang L; Liu L
    Prostate; 2018 May; 78(6):426-434. PubMed ID: 29383752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of specific HDAC6 inhibitor with anti-metastatic effects in pancreatic cancer cells through virtual screening and biological evaluation.
    Song H; Niu X; Quan J; Li Y; Yuan L; Wang J; Ma C; Ma E
    Bioorg Chem; 2020 Apr; 97():103679. PubMed ID: 32120077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial Hypertension.
    Boucherat O; Chabot S; Paulin R; Trinh I; Bourgeois A; Potus F; Lampron MC; Lambert C; Breuils-Bonnet S; Nadeau V; Paradis R; Goncharova EA; Provencher S; Bonnet S
    Sci Rep; 2017 Jul; 7(1):4546. PubMed ID: 28674407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-601 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma (ESCC) by targeting HDAC6.
    Liu C; Tian X; Sun HB; Wang ZF; Jiang LF; Li ZX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1069-1076. PubMed ID: 30779074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC6 interacts with PTPN1 to enhance melanoma cells progression.
    Liu J; Luan W; Zhang Y; Gu J; Shi Y; Yang Y; Feng Z; Qi F
    Biochem Biophys Res Commun; 2018 Jan; 495(4):2630-2636. PubMed ID: 29278704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic drugs in combination with the CXCR4 antagonist AMD3100 as a potential treatment option for pediatric rhabdomyosarcoma.
    Regenbogen S; Stagno MJ; Schleicher S; Schilbach K; Bösmüller H; Fuchs J; Schmid E; Seitz G
    Int J Oncol; 2020 Jul; 57(1):289-300. PubMed ID: 32377699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HDAC6 activity through interaction with RanBPM and its associated CTLH complex.
    Salemi LM; Maitland MER; Yefet ER; Schild-Poulter C
    BMC Cancer; 2017 Jul; 17(1):460. PubMed ID: 28668087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target.
    Kuda M; Kohashi K; Yamada Y; Maekawa A; Kinoshita Y; Nakatsura T; Iwamoto Y; Taguchi T; Oda Y
    Tumour Biol; 2016 Apr; 37(4):5213-23. PubMed ID: 26553361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of pannexin 1-regulated genes, interactome, and pathways in rhabdomyosarcoma and its tumor inhibitory interaction with AHNAK.
    Xiang X; Langlois S; St-Pierre ME; Blinder A; Charron P; Graber TE; Fowler SL; Baird SD; Bennett SAL; Alain T; Cowan KN
    Oncogene; 2021 Mar; 40(10):1868-1883. PubMed ID: 33564071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.